Polyganics BV (Polyganics) is a medical technology company that develops, manufactures and commercializes bioresorbable medical devices which facilitate tissue repair and regeneration. The company provides a range of products for ear, nose and throat (ENT) procedures; peripheral nerve repair (PNR) and neurosurgery; and general surgery. Its proprietary polymer technology platforms allow the creation of bioresorbable synthetic polymers for different clinical applications that improve surgical outcomes such as hemostatic control, drug elution, tissue regeneration, and others. Polyganics works in collaboration with other medical technology companies and academic centers for in-licensing and co-development of bioresorbable devices. The company distributes its products across various geographical regions including China, Australia, India, France, Brazil, Argentina, Mexico, Malaysia, Vietnam, Germany and the US, among others. Polyganics is headquartered in Groningen, the Netherlands.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Polyganics BV
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Polyganics BV Company Overview
- Polyganics BV Company Snapshot
- Polyganics BV Pipeline Products and Ongoing Clinical Trials Overview
- Polyganics BV - Pipeline Analysis Overview
- Polyganics BV - Key Facts
- Polyganics BV - Major Products and Services
- Polyganics BV Pipeline Products by Development Stage
- Polyganics BV Ongoing Clinical Trials by Trial Status
- Polyganics BV Pipeline Products Overview
- 3D Printed Scaffold
- 3D Printed Scaffold Product Overview
- ACTISEAL
- ACTISEAL Product Overview
- ACTISEAL Clinical Trial
- ACTISEAL - Adjacent Indications
- ACTISEAL - Adjacent Indications Product Overview
- Drug Eluting Device
- Drug Eluting Device Product Overview
- LIQOSEAL - Dura Sealing Patch
- LIQOSEAL - Dura Sealing Patch Product Overview
- LIQOSEAL - Dura Sealing Patch Clinical Trial
- LIQOSEAL - Spine Application
- LIQOSEAL - Spine Application Product Overview
- Neurolac Wrap
- Neurolac Wrap Product Overview
- Surgical Mesh
- Surgical Mesh Product Overview
- Polyganics BV - Key Competitors
- Polyganics BV - Key Employees
- Polyganics BV - Locations And Subsidiaries
- Head Office
- Recent Developments
- Polyganics BV, Recent Developments
- Jan 07, 2020: Polyganics achieves CE mark certification for LIQOSEAL
- Sep 17, 2019: Polyganics achieves positive 3-month follow-up data of ENCASE I, the first clinical trial for LIQOSEAL
- Apr 10, 2019: Polyganics builds new facility to continue growth, supported by RIG subsidy of €3.8 Million
- Oct 22, 2018: Polyganics initiates first-in-human trial of LIQOSEAL,its innovative approach for dural closure
- Sep 10, 2018: Polyganics strengthens global distribution network with appointment of Synovis MCA as US-wide distributor of NEUROCAP
- Mar 08, 2018: FDA Grants Breakthrough Device Designation to Polyganics’ Liver and Pancreas Sealant Patch
- Dec 01, 2017: Polyganics awarded €1.2 million to complete clinical development of dura sealant patch
- Sep 05, 2017: Polyganics Extends Global Distribution Network with the Addition of Multiple US Distributors
- Jun 08, 2017: Polyganics signs up multiple distributors in Europe to accelerate roll-out of Peripheral Nerve Repair portfolio
- Apr 20, 2017: Polyganics Announces Enrollment of the First Patient in its PROTECT NEURO Study
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Polyganics BV Pipeline Products and Ongoing Clinical Trials Overview
- Polyganics BV Pipeline Products by Equipment Type
- Polyganics BV Pipeline Products by Indication
- Polyganics BV Ongoing Clinical Trials by Trial Status
- Polyganics BV, Key Facts
- Polyganics BV, Major Products and Services
- Polyganics BV Number of Pipeline Products by Development Stage
- Polyganics BV Pipeline Products Summary by Development Stage
- Polyganics BV Ongoing Clinical Trials by Trial Status
- Polyganics BV Ongoing Clinical Trials Summary
- 3D Printed Scaffold - Product Status
- 3D Printed Scaffold - Product Description
- ACTISEAL - Product Status
- ACTISEAL - Product Description
- ACTISEAL - Prospective, Multicenter Study to Evaluate the Safety and Performance of a Synthetic Tissue Sealant in Reducing Fluid Leakage Following Elective hepatobiLiary and Pancreatic Surgery
- ACTISEAL - Adjacent Indications - Product Status
- ACTISEAL - Adjacent Indications - Product Description
- Drug Eluting Device - Product Status
- Drug Eluting Device - Product Description
- LIQOSEAL - Dura Sealing Patch - Product Status
- LIQOSEAL - Dura Sealing Patch - Product Description
- LIQOSEAL - Dura Sealing Patch - Randomized, Two-arm, Multicenter Study to Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
- LIQOSEAL - Spine Application - Product Status
- LIQOSEAL - Spine Application - Product Description
- Neurolac Wrap - Product Status
- Neurolac Wrap - Product Description
- Surgical Mesh - Product Status
- Surgical Mesh - Product Description
- Polyganics BV, Key Employees
- Glossary
- Polyganics BV Pipeline Products by Equipment Type
- Polyganics BV Pipeline Products by Development Stage
- Polyganics BV Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Curan Medical B.V.
- Elana bv
- Omron Healthcare Europe BV
- Rovers Medical Devices B.V.
